Ayşegül Güven1, Miray Altinkaynak1, Nazan Dolu2, Esra Demirci3, Sevgi Özmen3, Meltem İzzetoğlu4, Ferhat Pektaş5. 1. Department of Biomedical Engineering, Engineering Faculty, Erciyes University, Kayseri, Turkey. 2. Department of Physiology, Medical Faculty, Erciyes University, Kayseri, Turkey (retired). 3. Department of Psychiatry, Medical Faculty, Erciyes University, Kayseri, Turkey. 4. Electrical and Computer Engineering Department, Engineering Faculty, Villanova University, USA. 5. Department of Physiology, Medical Faculty, Altınbaş University, Turkey.
Abstract
INTRODUCTION: Attention-deficit/hyperactivity disorder (ADHD) is associated with a broad range of neuropsychological impairments that are attenuated with methylphenidate (MPH) treatment. The aim of this study was to determine how MPH effects attentional functioning in terms of reaction time (RT) in ADHD. METHODS: Eighteen pre-medicated ADHD children (7 to 12 years old) and eighteen gender matched normal controls (7 to 12 years old) were included in the study. Participants performed an auditory attention task and the RT of participants to each target response was calculated automatically. The same test was repeated 3 months after OROS-MPH administration for ADHD group. RT, RT standard deviation (RTSD), and response errors (omission and commission errors) were compared between control and pre-MPH ADHD groups, and between Pre-MPH and post-MPH ADHD groups. RESULTS: Relative to control subjects, significantly longer RTs, higher RTSD and more errors of omission were observed in unmedicated ADHD children during auditory attention task. Analyses revealed significant effects of medication across all measures except commission errors. After treatment RTs were faster, RTSD values were lower, and errors of omission were attenuated compared to pre-medication condition in ADHD group. There were no significant differences in terms of commission errors between groups. CONCLUSION: In this study it was observed that MPH reduced RTs to stimuli, attenuated omission errors during the task in ADHD group and after 3 months of treatment ADHD children showed similar patterns in RT as compared to controls. Results suggest that when treating ADHD, it might help clinicians to evaluate objective and non-invasive cognitive outcomes such as RT, RTSD and response errors to evaluate the effects of treatment.
INTRODUCTION: Attention-deficit/hyperactivity disorder (ADHD) is associated with a broad range of neuropsychological impairments that are attenuated with methylphenidate (MPH) treatment. The aim of this study was to determine how MPH effects attentional functioning in terms of reaction time (RT) in ADHD. METHODS: Eighteen pre-medicated ADHD children (7 to 12 years old) and eighteen gender matched normal controls (7 to 12 years old) were included in the study. Participants performed an auditory attention task and the RT of participants to each target response was calculated automatically. The same test was repeated 3 months after OROS-MPH administration for ADHD group. RT, RT standard deviation (RTSD), and response errors (omission and commission errors) were compared between control and pre-MPH ADHD groups, and between Pre-MPH and post-MPH ADHD groups. RESULTS: Relative to control subjects, significantly longer RTs, higher RTSD and more errors of omission were observed in unmedicated ADHD children during auditory attention task. Analyses revealed significant effects of medication across all measures except commission errors. After treatment RTs were faster, RTSD values were lower, and errors of omission were attenuated compared to pre-medication condition in ADHD group. There were no significant differences in terms of commission errors between groups. CONCLUSION: In this study it was observed that MPH reduced RTs to stimuli, attenuated omission errors during the task in ADHD group and after 3 months of treatment ADHD children showed similar patterns in RT as compared to controls. Results suggest that when treating ADHD, it might help clinicians to evaluate objective and non-invasive cognitive outcomes such as RT, RTSD and response errors to evaluate the effects of treatment.
Authors: A Marije Boonstra; J J Sandra Kooij; Jaap Oosterlaan; Joseph A Sergeant; Jan K Buitelaar Journal: J Clin Exp Neuropsychol Date: 2005-04 Impact factor: 2.475
Authors: Jeffery N Epstein; Alaatin Erkanli; C Keith Conners; John Klaric; Jane E Costello; Adrian Angold Journal: J Abnorm Child Psychol Date: 2003-10
Authors: Chantal Kemner; Lisa M Jonkman; J Leon Kenemans; Koen B E Böcker; Marinus N Verbaten; Herman Van Engeland Journal: Biol Psychiatry Date: 2004-04-01 Impact factor: 13.382
Authors: Brian F O'Donnell; William P Hetrick; Jenifer L Vohs; Giri P Krishnan; Christine A Carroll; Anantha Shekhar Journal: Neuroreport Date: 2004-06-07 Impact factor: 1.837
Authors: Aurina Arnatkeviciute; Mark A Bellgrove; Mia Moses; Jeggan Tiego; Ditte Demontis; G Bragi Walters; Hreinn Stefansson; Kari Stefansson; Anders D Børglum Journal: Mol Psychiatry Date: 2022-09-23 Impact factor: 13.437
Authors: Barbara D'Aiello; Silvia Di Vara; Pietro De Rossi; Italo Pretelli; Stefano Vicari; Deny Menghini Journal: Int J Environ Res Public Health Date: 2022-01-31 Impact factor: 3.390